Baz M - Search Results

1

Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus.

Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, De Serres G, Boivin G. Papenburg J, et al. Among authors: baz m. Clin Vaccine Immunol. 2011 Mar;18(3):520-2. doi: 10.1128/CVI.00449-10. Epub 2011 Jan 12. Clin Vaccine Immunol. 2011. PMID: 21228145 Free PMC article.

2

Infections by human coronavirus-NL in hospitalized children.

Boivin G, Baz M, Côté S, Gilca R, Deffrasnes C, Leblanc E, Bergeron MG, Déry P, De Serres G. Boivin G, et al. Among authors: baz m. Pediatr Infect Dis J. 2005 Dec;24(12):1045-8. doi: 10.1097/01.inf.0000183743.68569.c7. Pediatr Infect Dis J. 2005. PMID: 16371863

3

Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.

Baz M, Abed Y, McDonald J, Boivin G. Baz M, et al. Clin Infect Dis. 2006 Dec 15;43(12):1555-61. doi: 10.1086/508777. Epub 2006 Nov 8. Clin Infect Dis. 2006. PMID: 17109288

4

Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.

Baz M, Abed Y, Boivin G. Baz M, et al. Antiviral Res. 2007 May;74(2):159-62. doi: 10.1016/j.antiviral.2006.10.012. Epub 2006 Nov 20. Antiviral Res. 2007. PMID: 17137644

5

Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.

Abed Y, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. Antivir Ther. 2006;11(8):971-6. Antivir Ther. 2006. PMID: 17302366

6

Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.

Abed Y, Nehmé B, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. Antiviral Res. 2008 Feb;77(2):163-6. doi: 10.1016/j.antiviral.2007.08.008. Epub 2007 Sep 10. Antiviral Res. 2008. PMID: 17919743

7

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

Denis J, Acosta-Ramirez E, Zhao Y, Hamelin ME, Koukavica I, Baz M, Abed Y, Savard C, Pare C, Lopez Macias C, Boivin G, Leclerc D. Denis J, et al. Among authors: baz m. Vaccine. 2008 Jun 25;26(27-28):3395-403. doi: 10.1016/j.vaccine.2008.04.052. Epub 2008 May 12. Vaccine. 2008. PMID: 18511159

8

Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice.

Baz M, Abed Y, Nehmé B, Boivin G. Baz M, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):791-3. doi: 10.1128/AAC.01276-08. Epub 2008 Nov 17. Antimicrob Agents Chemother. 2009. PMID: 19015327 Free PMC article.

9

A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.

Abed Y, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. J Infect Dis. 2009 Jan 15;199(2):180-3. doi: 10.1086/595736. J Infect Dis. 2009. PMID: 19046066

10

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Baz M, et al. N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters